Free to Breathe has undertaken the bold, yet attainable, goal of doubling the survival rate of those diagnosed with lung cancer by 2022. Comprised of lung cancer survivors, leading medical practitioners, respected research authorities, advocates and other industry leaders, Free to Breathe is a representative of those affected by and fighting for a cure for lung cancer. Free to Breathe utilizes a multifaceted approach of funding cutting edge research, providing information on current treatment options and ensuring patients benefit from innovative therapies. Through its work, Free to Breathe provides the thousands diagnosed with lung cancer each year the hope of an eventual cure. For more information, visit www.freetobreathe.org.